OMNY Health, which assists hospitals in monetizing operational data, has launched an AI-powered platform for health technology companies to leverage its data on more than 75 million patients.
The first two companies to utilize this data are QuantHealth, an AI-enabled clinical trial design company, and ArisGlobal, a life sciences company. QuantHealth will add OMNY’s data to its existing AI technology, which is trained on a dataset of 350 million patients. This collaboration aims to speed up drug development via simulated clinical trials and predict clinical trial outcomes, patient responses, and drug efficacy.
ArisGlobal, which focuses on drug development safety monitoring and clinical research, will utilize the OMNY platform to mitigate trial risks, identify populations more likely to respond to treatments, and improve clinical trial timelines. ArisGlobal currently offers LifeSphere, a research and development software platform for life sciences companies.
Mitesh Rao, CEO of OMNY Health, stated, “Our mission is to free data from silos, allowing it to be shared, analyzed, and morphed into lifesaving treatments and better care for patients.” The goal is to alleviate time and budget constraints for life science organizations by partnering with AI developers to accelerate breakthrough therapies and monitor new therapies for safety signals.
ArisGlobal had previously collaborated with OMNY Health, launching a Real-World Data (RWD) data subscription within its LifeSphere Safety platform earlier this year. This effort aimed to transform safety signal validation within clinical trials.
OMNY also collaborated with data-sharing technology startup Datavant to expedite the delivery of real-world deidentified data from provider organizations to drug developers and clinical researchers. This allows providers to access OMNY’s offerings via Datavant’s platform, converting their EHR data into research-ready datasets.
QuantHealth secured funding last year to enhance its clinical trial-focused platform. It raised $15 million in Series A funding and added further investment earlier this year, bringing its total Series A raise to $17 million.
Source: OMNY Health unveils AI data platform for health tech companies.
